Does Modified Ultrafiltration Improves Inflammatory Response and Cardiopulmonary Function After CABG Procedures?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01140113|
Recruitment Status : Completed
First Posted : June 9, 2010
Last Update Posted : July 23, 2013
University of Campinas, Brazil
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by (Responsible Party):
Orlando Petrucci, University of Campinas, Brazil
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||July 2008|
|Actual Study Completion Date :||March 2009|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Torina AG, Silveira-Filho LM, Vilarinho KA, Eghtesady P, Oliveira PP, Sposito AC, Petrucci O. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg. 2012 Sep;144(3):663-70. doi: 10.1016/j.jtcvs.2012.04.012. Epub 2012 May 9.